Cargando…

Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients

OBJECTIVES: To evaluate the association between AGEs and atherosclerotic lipid profiles among aging diabetic patients in Taiwan. DESIGN AND METHODS: After age and gender matching, we selected 207 diabetic subjects and 174 diabetic subjects with proteinuria. Lipid profiles, including total cholestero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Jin-Biou, Chu, Nain-Feng, Syu, Jhu-Ting, Hsieh, An-Tsz, Hung, Yi-Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293095/ https://www.ncbi.nlm.nih.gov/pubmed/22142413 http://dx.doi.org/10.1186/1476-511X-10-228

Ejemplares similares

Soluble Form of Receptor for Advanced Glycation End Products Is Associated with Obesity and Metabolic Syndrome in Adolescents
por: He, Chih-Tsueng, et al.
Publicado: (2014)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Visceral adiposity index, lipid accumulation product and intracranial atherosclerotic stenosis in middle-aged and elderly Chinese
por: Li, Rui, et al.
Publicado: (2017)

Advanced Glycation End-Products in Skeletal Muscle Aging
por: Olson, Lucas C., et al.
Publicado: (2021)

The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still’s disease
por: Chen, Der-Yuan, et al.
Publicado: (2015)

The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer’s Disease
por: Ko, Shun-Yao, et al.
Publicado: (2015)

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
por: Pinto, Raphael S, et al.
Publicado: (2022)

Abstract: Perceived Facial Aging: The Role of AGES (Advanced Glycation End Products)
por: Lee, Jonathan Y., et al.
Publicado: (2017)

Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs
por: Lee, Eun Jung, et al.
Publicado: (2016)

Advanced glycation end products: Key players in skin aging?
por: Gkogkolou, Paraskevi, et al.
Publicado: (2012)

Advanced glycation end products regulate the receptor of AGEs epigenetically
por: Wu, Xiaoqing, et al.
Publicado: (2023)

A Role for Advanced Glycation End Products in Molecular Ageing
por: Zgutka, Katarzyna, et al.
Publicado: (2023)

Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature
por: Asadipooya, Kamyar, et al.
Publicado: (2019)

Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases
por: Moldogazieva, Nurbubu T., et al.
Publicado: (2019)

Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging
por: Portero-Otin, Manuel, et al.
Publicado: (2023)

Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes
por: Chang, Chia-Chu, et al.
Publicado: (2017)

Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs
por: Twarda-Clapa, Aleksandra, et al.
Publicado: (2022)

Association between interleukin-6 receptor gene variations and atherosclerotic lipid profiles among young adolescents in Taiwan
por: Chu, Nain-Feng, et al.
Publicado: (2011)

The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway
por: Ren, Liuyang, et al.
Publicado: (2021)

Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN)
por: Yuan, Yang, et al.
Publicado: (2017)

Prevalence and trend of dyslipidaemia from 1996 to 2006 among normal and overweight adolescents in Taiwan
por: Kuo, Philip, et al.
Publicado: (2014)

The relationship between sex hormones and glycated hemoglobin in a non-diabetic middle-aged and elderly population
por: Xu, Yiting, et al.
Publicado: (2022)

Advanced glycation end product (AGE) modified proteins in tears of diabetic patients
por: Zhao, Zhenjun, et al.
Publicado: (2010)

The Contribution of Advanced Glycation End product (AGE) accumulation to the decline in motor function
por: Drenth, Hans, et al.
Publicado: (2016)

Phagocytosis of Advanced Glycation End Products (AGEs) in Macrophages Induces Cell Apoptosis
por: Gao, Yuan, et al.
Publicado: (2017)

Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
por: Yamagishi, Sho-ichi, et al.
Publicado: (2018)

In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration
por: Chrysanthou, Marialena, et al.
Publicado: (2022)

Association of Advanced Glycation End Products With Lower-Extremity Atherosclerotic Disease in Type 2 Diabetes Mellitus
por: Ying, Lingwen, et al.
Publicado: (2021)

Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?
por: Fotheringham, Amelia K., et al.
Publicado: (2022)

The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases
por: Shen, Chieh-Yu, et al.
Publicado: (2020)

Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
por: Chang, Jui-Ting, et al.
Publicado: (2017)

Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury
por: Rungratanawanich, Wiramon, et al.
Publicado: (2021)

The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs
por: Xue, Jing, et al.
Publicado: (2014)

Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease
por: Nenna, Antonio, et al.
Publicado: (2015)

Knockout of receptor for advanced glycation end‐products attenuates age‐related renal lesions
por: Teissier, Thibault, et al.
Publicado: (2019)

Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects
por: Perrone, Anna, et al.
Publicado: (2020)

Relationships between advanced glycation end products (AGEs), vasoactive substances, and vascular function
por: Matsumoto, Takayuki, et al.
Publicado: (2022)

Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis
por: Scavello, Francesco, et al.
Publicado: (2021)

Serum Fluorescent Advanced Glycation End (F-AGE) products in gestational diabetes patients
por: Lobo, João Paulo, et al.
Publicado: (2017)

Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease
por: Dozio, Elena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hst8e5kusupgc7k69v04j17mfu